Alcohol and substance addiction is a progressive brain disease that is widespread globally and poses a significant threat to life. It ranks among the top causes of death worldwide. Without early diagnosis and access to appropriate treatment, the destructive effects of substance use can lead to chronic physical and mental illnesses.

Addiction can cause various levels of impairment across all bodily systems. For instance, it can result in digestive system issues, toxic hepatitis, cirrhosis, hepatitis C, and AIDS. Cardiovascular diseases, respiratory diseases, and even respiratory arrest can occur due to excessive substance use in the pursuit of the former pleasurable effects.

Addiction is a lifelong condition marked by periods of flare-ups and remissions. It is a serious issue that requires formal treatment. Addiction treatments are provided in Alcohol and Substance Use Disorders Treatment Centers (AMATEMs). However, due to the mental, physical, and social disabilities caused by addiction, patients often struggle to access the necessary treatment.

To prevent the progression of alcohol, cannabis, and heroin addiction, an effective pharmacological drug called Naltrexone is available. It comes in oral tablets, monthly injections, and slow-release implant forms. Since using heroin while under Naltrexone treatment can be fatal, laws allow this drug to be prescribed and administered only by a psychiatry specialist trained in addiction treatment. Although the regulations for using this drug are strict, there are cases of overt or covert boundary violations and uncontrolled applications.

Naltrexone subcutaneous implant applications are often referred to as 'chip therapy' among addicts. The high hopes and excessive expectations surrounding this treatment can drive patients and their families to seek it through inappropriate means. One of our primary responsibilities as addiction psychiatrists is to inform the public about this issue.